Influence of ADAM10 Polymorphisms on Plasma Level of Soluble Receptor for Advanced Glycation End Products and The Association With Alzheimer's Disease Risk.
Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease.
Movement Disorders : Official Journal Of The Movement Disorder Society
Bekris, Lynn M LM; Tsuang, Debby W DW; Peskind, Elaine R ER; Yu, Chang E CE; Montine, Thomas J TJ; Zhang, Jing J; Zabetian, Cyrus P CP; Leverenz, James B JB
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
Neurobiology Of Aging
Bekris, L M LM; Galloway, N M NM; Millard, S S; Lockhart, D D; Li, G G; Galasko, D R DR; Farlow, M R MR; Clark, C M CM; Quinn, J F JF; Kaye, J A JA; Schellenberg, G D GD; Leverenz, J B JB; Seubert, P P; Tsuang, D W DW; Peskind, E R ER; Yu, C E CE
Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.
Human Molecular Genetics
Kim, Minji M; Suh, Jaehong J; Romano, Donna D; Truong, Mimy H MH; Mullin, Kristina K; Hooli, Basavaraj B; Norton, David D; Tesco, Giuseppina G; Elliott, Kathy K; Wagner, Steven L SL; Moir, Robert D RD; Becker, K David KD; Tanzi, Rudolph E RE